These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 1452292

  • 21. A highly potent and long-acting oral inhibitor of human renin.
    Hiwada K, Kokubu T, Murakami E, Muneta S, Morisawa Y, Yabe Y, Koike H, Iijima Y.
    Hypertension; 1988 Jun; 11(6 Pt 2):708-12. PubMed ID: 3134306
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Disparity between blood pressure and PRA inhibition after administration of a renin inhibitor to anesthetized dogs: methodological considerations.
    Palmer RK, Rapundalo ST, Batley BL, Barnes AE, Singh S, Ryan MJ, Taylor DG.
    Clin Exp Hypertens; 1993 Jul; 15(4):663-81. PubMed ID: 8374609
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of renin inhibition in the conscious primate Macaca fascicularis.
    Hui KY, Knight DR, Nussberger J, Hartley LH, Vatner SF, Haber E.
    Hypertension; 1989 Nov; 14(5):480-7. PubMed ID: 2680962
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Studies directed toward the design of orally active renin inhibitors. 2. Development of the efficacious, bioavailable renin inhibitor (2S)-2-benzyl-3- [[(1-methylpiperazin-4-yl)sulfonyl]propionyl]-3-thiazol-4-yl-L-alanine amide of (2S,3R,4S)-2-amino-1-cyclohexyl-3,4-dihydroxy-6-methylheptane (A-72517).
    Rosenberg SH, Spina KP, Condon SL, Polakowski J, Yao Z, Kovar P, Stein HH, Cohen J, Barlow JL, Klinghofer V.
    J Med Chem; 1993 Feb 19; 36(4):460-7. PubMed ID: 8474102
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of chronic infusion of renin inhibitor A-64662 in sodium-depleted monkeys.
    Verburg KM, Kleinert HD, Kadam JR, Chekal MA, Mento PF, Wilkes BM.
    Hypertension; 1989 Mar 19; 13(3):262-72. PubMed ID: 2646217
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Evaluation of a potent inhibitor of subprimate and primate renins.
    Wood JM, Mah SC, Baum HP, de Gasparo M, Cumin F, Rüeger H, Nussberger J.
    J Pharmacol Exp Ther; 1990 May 19; 253(2):513-7. PubMed ID: 2110974
    [Abstract] [Full Text] [Related]

  • 37. ES-8891, an orally active inhibitor of human renin.
    Kokubu T, Hiwada K, Murakami E, Muneta S, Kitami Y, Salmon PF.
    Hypertension; 1990 Jun 19; 15(6 Pt 2):909-13. PubMed ID: 2112512
    [Abstract] [Full Text] [Related]

  • 38. CP-71,362: a pentapeptide renin inhibitor selective for the canine enzyme.
    Mangiapane ML, MacAndrew JT, Ellery SS, Smith AH, Purcell IM, Kleinman EF, Holt WF, Murphy WR.
    Clin Exp Hypertens; 1994 Jul 19; 16(4):507-33. PubMed ID: 7920458
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M, Schiavi P, Vincent M, Schmitt H.
    J Cardiovasc Pharmacol; 1984 Jul 19; 6(6):1076-82. PubMed ID: 6084763
    [Abstract] [Full Text] [Related]

  • 40. Cardiovascular actions of the primate-selective renin inhibitor, A-62198.
    Kleinert HD, Martin D, Chekal M, Young G, Rosenberg S, Plattner JJ, Perun TJ.
    J Pharmacol Exp Ther; 1988 Sep 19; 246(3):975-9. PubMed ID: 3047366
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.